Cargando…

Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease

Parkin and α-synuclein are two key proteins involved in the pathophysiology of Parkinson’s disease (PD). Neurotoxic alterations of α-synuclein that lead to the formation of toxic oligomers and fibrils contribute to PD through synaptic dysfunction, mitochondrial impairment, defective endoplasmic reti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madsen, Daniel Aghaie, Schmidt, Sissel Ida, Blaabjerg, Morten, Meyer, Morten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911026/ https://www.ncbi.nlm.nih.gov/pubmed/33572534 http://dx.doi.org/10.3390/cells10020283

Ejemplares similares

RhoA Signaling in Neurodegenerative Diseases
por: Schmidt, Sissel Ida, et al.
Publicado: (2022)

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
por: Khandelwal, Preeti J, et al.
Publicado: (2010)

Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
por: Elfarrash, Sara, et al.
Publicado: (2021)

Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
por: Lonskaya, Irina, et al.
Publicado: (2013)

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease
por: Fiala, Ondrej, et al.
Publicado: (2014)

Effect of Parkin on methamphetamine‐induced α‐synuclein degradation dysfunction in vitro and in vivo
por: Meng, Yunle, et al.
Publicado: (2020)

Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation
por: Okarmus, Justyna, et al.
Publicado: (2020)

The Parkinson’s disease genes Fbxo7 and Parkin interact to mediate mitophagy
por: Burchell, Victoria S, et al.
Publicado: (2013)

Differential mitochondrial roles for α-synuclein in DRP1-dependent fission and PINK1/Parkin-mediated oxidation
por: Krzystek, Thomas J., et al.
Publicado: (2021)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
por: Ahmed, Sanaa, et al.
Publicado: (2022)

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson’s Disease
por: Bobela, Wojciech, et al.
Publicado: (2015)

Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synuclein
por: Chung, Eunna, et al.
Publicado: (2020)

Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson’s disease
por: Jensen, Bente Rona, et al.
Publicado: (2021)

Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson’s disease
por: Park, Soo Jin, et al.
Publicado: (2021)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, PINK1 and PARK9
por: Bohush, Anastasiia, et al.
Publicado: (2021)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson’s Disease Models In Vivo and In Vitro
por: Hsu, Yu-Ling, et al.
Publicado: (2021)

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
por: Post, Michael R., et al.
Publicado: (2018)

Endonuclease G mediates α-synuclein cytotoxicity during Parkinson’s disease
por: Büttner, Sabrina, et al.
Publicado: (2013)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson’s disease
por: Chen, Jialong, et al.
Publicado: (2018)

Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
por: Wilkaniec, Anna, et al.
Publicado: (2021)

Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease
por: Castillo-Quan, Jorge Iván
Publicado: (2011)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
por: Guerreiro, Patrícia Silva, et al.
Publicado: (2012)

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease
por: Matrone, Carmela, et al.
Publicado: (2016)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Non-Cell-Autonomous Neurotoxicity in Parkinson’s Disease Mediated by Astroglial α-Synuclein
por: Chai, MuhChyi, et al.
Publicado: (2019)

Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential
por: Ferreira, Nelson, et al.
Publicado: (2021)

Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice
por: Fournier, Margot, et al.
Publicado: (2013)

Comparative Analysis of Spontaneous and Stimulus-Evoked Calcium Transients in Proliferating and Differentiating Human Midbrain-Derived Stem Cells
por: Johansen, Torben, et al.
Publicado: (2017)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7nu59tr3q8h1ss587n4educsuo